0001908231-22-000001.txt : 20220201 0001908231-22-000001.hdr.sgml : 20220201 20220201145626 ACCESSION NUMBER: 0001908231-22-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220201 DATE AS OF CHANGE: 20220201 EFFECTIVENESS DATE: 20220201 FILER: COMPANY DATA: COMPANY CONFORMED NAME: FireCyte Therapeutics, Inc. CENTRAL INDEX KEY: 0001908231 IRS NUMBER: 872790633 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-431729 FILM NUMBER: 22578458 BUSINESS ADDRESS: STREET 1: 215 FIRST STREET, SUITE 500 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 5083442319 MAIL ADDRESS: STREET 1: 215 FIRST STREET, SUITE 500 CITY: CAMBRIDGE STATE: MA ZIP: 02142 D 1 primary_doc.xml X0708 D LIVE 0001908231 FireCyte Therapeutics, Inc. 215 FIRST STREET, SUITE 500 CAMBRIDGE MA MASSACHUSETTS 02142 5083442319 DELAWARE None None Corporation true 2021 William E Yelle 215 First Street, Suite 500 Cambridge MA MASSACHUSETTS 02142 Executive Officer Director Meredith Fisher c/o FireCyte Therapeutics, Inc. 215 First Street, Suite 500 Cambridge MA MASSACHUSETTS 02142 Director Charles Kunsch c/o FireCyte Therapeutics, Inc. 215 First Street, Suite 500 Cambridge MA MASSACHUSETTS 02142 Director Ruoxi Hu c/o FireCyte Therapeutics, Inc. 215 First Street, Suite 500 Cambridge MA MASSACHUSETTS 02142 Director Other Decline to Disclose 06b false 2022-01-14 false true false 0 11999994 5499998 6499996 false 3 0 0 0 false FireCyte Therapeutics, Inc. /s/ William E. Yelle William E. Yelle Chief Executive Officer 2022-02-01